NEJM and ACC posts report SMART-DECISION found stopping beta-blockers was noninferior to continuing them in stable, low-risk patients who had taken beta-blockers for at least one year after myocardial infarction.
Original Article: Discontinuation of Beta-Blocker Therapy after Myocardial Infarction (SMART-DECISION trial)
Discontinuing beta-blocker therapy was found to be noninferior to continuing the therapy among stable, low-risk patients who took it for at least one year following a #cvMI.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare